DVYSR.ST - Devyser Diagnostics AB (publ)

Devyser Diagnostics AB (publ)

Instrumentvägen 19
Hägersten 126 53
Sweden
46 8 56 21 58 50
https://devyser.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 102

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Fredrik Alpsten	Chief Exec. Officer	4.16M	N/A	1966
Mr. Ulf Klangby	Founder & Deputy CEO	N/A	N/A	1969
Ms. Sabina Berlin	Chief Financial Officer	N/A	N/A	1983
Mr. Goran Rydin	Chief Operating Officer	N/A	N/A	1969
Ms. Camilla Wiberg	Chief Human Resource Officer	N/A	N/A	1979
Mr. Theis Kipling	Chief Commercial Officer	N/A	N/A	1982
Mr. John Murad	VP & GM of Devyser US	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Devyser Diagnostics AB (publ) provides diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation, thalassemia, breast and ovarian cancer, non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company was incorporated in 2004 and is based in Hägersten, Sweden.

Corporate Governance

Devyser Diagnostics AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.